Related to this topic: Patient+ | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Placenta And Placental Problems
Placenta is derived from both maternal and fetal tissue with approximately one fifth derived from fetal tissue at term. It comprises a large number of functional units called villi which are branched terminals of the fetal circulation allowing transfer of metabolic products.
At term, the normal placenta:
- Is blue-red in colour and discoid in shape
- 15-22cm diameter
- 2-4cm thick
- Weighs 400-600g (15% normal neonatal weight)
- Has a maternal surface that is divided into lobules or cotyledons with irregular grooves or clefts.
- Has a smooth, shiny, translucent fetal surface covered in amniotic membrane.
The normal umbilical cord:
- Is 55-60cm long and 2-2.5cm in diameter
- Should have abundant Wharton's jelly with no true knots
- Contains 2 arteries and 1 vein
- Can arise from any point on the fetal surface of the placenta.
Circumvallate
In approximately 1% of cases, there is a small central chorionic area inside a paler thick ring of membranes on the fetal side of the placenta. This is associated with an increased rate of antepartum bleeding, prematurity, abruption, multiparity and perinatal death.
Succenturiate lobe
These are accessory lobes. Large torn vessels within the fetal membranes but beyond the edge of the delivered placenta are suggestive of an undelivered lobe and the uterus should be further explored for retrieval. Succenturiate lobes are associated with retained placenta and increased risk of postpartum infection and haemorrhage.
Bipartite placenta
This is uncommon: the placenta appears as a bilobed structure joined by main vessels and membranes. If retained after birth, it can cause bleeding and septic complications. Again one should examine a small placenta for evidence of missing lobe and recover without delay.
Placenta membranacea
Failure of the chorion laeve to atrophy means that placental cotyledons form an envelope around the greater part of the uterine wall. This is associated with ante and postpartum haemorrhage and retained placenta.
Placenta in multiple pregnancy
Fraternal twins have either two distinct placentas or fused but there are always two distinct chorions and amnions. With identical twins the situation depends upon the timing of the division of the fertilized ovum: they can have two distinct placentas and sets of membranes or many different types of fusion with possible interchange of blood supply.
Placenta accreta/percreta/increta2,3
These are conditions where the placenta is abnormally strongly attached to the uterine wall. Incidence is about 1/2,500 deliveries. All are associated with retained placenta requiring surgical removal and high risk of postpartum haemorrhage. It may be partial (accreta where there is diffuse penetration into the myometrium), more significant as the myometrium is deeply invaded(placenta increta) or even crossing the uterine wall and invading the peritoneum (placenta percreta).
Risk factors4
- Previous caesarian section
- Placenta praevia
- Advanced maternal age.
The incidence of placenta accreta is thought to be increasing due to the rise in caesarian section deliveries.
Management
RCOG guidelines5 suggest:
- Where available, colour flow Doppler ultrasonography should be performed in women with placenta praevia to antenatally diagnose a morbidly adherent placenta. Where this is not available locally, they should be managed as if they have placenta accreta until proved otherwise.
- Where placenta accreta is thought likely, consultant anaesthetists and obstetricians should plan and manage the delivery. Crossmatched blood should be available. The risk of haemorrhage, transfusion and hysterectomy should be discussed with the patient as part of the consent process.
Repeated attempts to manually remove a placenta accreta can produce severe haemorrhage and the treatment in this circumstance is usually hysterectomy. Conservative management is sometimes applied where the preservation of fertility is paramount (leaving the placenta in place with or without therapeutic uterine artery embolisation or surgical internal iliac artery ligation or methotrexate therapy) but these may be complicated by delayed haemorrhage and the ultimate necessity of hysterectomy.
| Retained placenta This occurs when placenta remains in uterus for more than 1 hour. A physiological third stage takes about 30 minutes and the use of syntometrine and controlled cord traction to actively manage the third stage usually means delivery is achieved in 10 minutes. A retained placenta risks post-partum haemorrhage. If the placenta does not separate readily:
|
Placental abruption2
Separation of the placenta before delivery of the fetus occurs in approx. 1/77-89 deliveries causing bleeding from the placental bed of a normally situated placenta. Severe form occurs in 1/500-750 deliveries causing fetal death.
Risk factors
Trauma (RTA or iatrogenic eg ECV), PET, multiparity, previous abruption.
There are two main forms: concealed where haemorrhage is confined within the uterine cavity (20% of cases) and is the more severe form and revealed (80%) where blood drains through the cervix, usually with incomplete placental detachment and fewer associated problems.
Presentation
- Usually with sudden abdominal pain and shock
- Hard, tender, 'woody' uterus
- Fetal parts difficult to palpate
- Where <1000ml blood has been lost, the fetus is hypoxic and may show signs of fetal distress
- Where >1500ml blood has been lost, the woman is usually in shock and the fetus is dead.
Treatment is to restore blood volume and deliver baby immediately.
Marginal haemorrhage - occurs with a painless bleed and clot located along the margin of the placenta with no distortion of its shape. It is usually due to the rupture of a marginal sinus. Women should be admitted for observation and fetal monitoring.
See seperate article on Placenta praevia
Marginal insertion of cord (Battledore)
Where the cord has a marginal rather than central insertion to the placenta. Not of clinical significance
Velamentous cord insertion
Where the placenta has developed away from the attachment of the cord and the vessels divide in the membrane. If they cross the lower pole of the chorion, this is known as vasa praevia and there is high risk of fetal haemorrhage and death at rupture of membranes. It can be diagnosed prenatally by ultrasound examination and good outcome depends on prenatal diagnosis and elective caesarian section prior to the rupture of membranes.3
Abnormal length of cord
A long cord (>100cm) is associated with increased risk of fetal entanglement, knots and prolapse of the cord. A short cord (<40cm) may be associated with a poorly active fetus, Down syndrome, cord rupture, breech position, prolonged second stage, uterine inversion and abruption. A normal length cord may become relatively short because of multiple looping around the baby's neck.
Abnormal number of vessels
A single uterine artery is associated with increased risk of fetal anomalies and cord compression.
Document references
- Yetter JF 3rd; Examination of the placenta.; Am Fam Physician. 1998 Mar 1;57(5):1045-54. [abstract]
- Current obstetric and gynaecologic diagnosis and treatment. DeCherney AH and Nathan L 9th Edition - pages 54, 55 and 357. Lang Medical Books. 2003
- Oyelese Y, Smulian JC; Placenta previa, placenta accreta, and vasa previa.; Obstet Gynecol. 2006 Apr;107(4):927-41. [abstract]
- Wu S, Kocherginsky M, Hibbard JU; Abnormal placentation: twenty-year analysis.; Am J Obstet Gynecol. 2005 May;192(5):1458-61. [abstract]
- RCOG Greentop Guidelines; No.27: Placenta praevia and placenta praevia accreta: diagnosis and management. Last revised Oct 2005
- Carroli G, Bergel E; Umbilical vein injection for management of retained placenta.; Cochrane Database Syst Rev. 2001;(4):CD001337. [abstract]
Internet and further reading Acknowledgements EMIS is grateful to Dr Chloe Borton for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 739
Document Version: 21
DocRef: bgp159
Last Updated: 19 Sep 2006
Review Date: 18 Sep 2008
Advert
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Placenta And Placental Problems' (1 there)Medical reference articles in PatientPlus related to this topic (^ top of page)
Anti-D (Rho) Immunoglobulin
Retained PlacentaOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

